Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $2.4 million.

  • Axogen's Cash from Financing Activities rose 31853.15% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 29718.07%. This contributed to the annual value of $2.3 million for FY2024, which is 1719.55% up from last year.
  • Axogen's Cash from Financing Activities amounted to $2.4 million in Q3 2025, which was up 31853.15% from $1.2 million recorded in Q2 2025.
  • Axogen's 5-year Cash from Financing Activities high stood at $18.1 million for Q2 2021, and its period low was $5000.0 during Q3 2023.
  • Over the past 5 years, Axogen's median Cash from Financing Activities value was $671000.0 (recorded in 2022), while the average stood at $1.7 million.
  • Per our database at Business Quant, Axogen's Cash from Financing Activities tumbled by 9767.44% in 2023 and then surged by 1134000.0% in 2024.
  • Over the past 5 years, Axogen's Cash from Financing Activities (Quarter) stood at $1.0 million in 2021, then fell by 22.05% to $813000.0 in 2022, then plummeted by 48.59% to $418000.0 in 2023, then skyrocketed by 132.06% to $970000.0 in 2024, then soared by 146.8% to $2.4 million in 2025.
  • Its Cash from Financing Activities was $2.4 million in Q3 2025, compared to $1.2 million in Q2 2025 and $2.4 million in Q1 2025.